Peritoneal Dialysis and Infection by Hepatitis B and C Virus

Puttinger H. , Wychtyl A. Hepatitis B and C in peritoneal dialysis patients. Semin Nephrol 2002; 22: 351–60.

Friedman E.A. , Thomson G.E. Hepatitis complicating chronic hemodialysis. Lancet 1966; 2: 675–8.

Goldsmith H.J. , Roberts C. , Wright F.K. , Roberts C. , Watson D.C. Viral hepatitis- a staff hazard in dialysis units. Lancet 1967; 1: 835–40.

Turner G.C. , Bruce White G.B. SH antigen in hemodialysis-associated hepatitis. Lancet 1969; 2: 121–5.

Hennekins C.H. Hemodialysis-associated hepatitis. JAMA 1973; 225: 407–8.

London S.T. , Di Figlia M. , Sutnick A.I. , Blumberg B.S. An epidemic of hepatitis in a chronic hemodialysis unit. N Engl J Med 1969; 281: 471–8.

Cacciatore L. , Molinari V. , Guadagnino V. , Tultio Cataldo P. Hepatitis B antigen in ascitic fluid in cirrhosis. Br Med J 1973; iii: 172–3.

Oreopoulos D.G. Hepatitis and treatment of chronic renal failure by peritoneal dialysis. Lancet 1972; 2: 1256.

Spector D. Hepatitis B miniepidemic in a peritoneal dialysis unit. Arch Intern Med 1977; 137: 1030–1.

Goodman W. , Gallagher N. , Sherrard D.J. Peritoneal dialysis fluid as a source of hepatitis antigen. Nephron 1981; 29: 107–9.

Vas S.I. , Oreopoulos D.G. Handle with care: Hepatitis B antigen carriers in peritoneal dialysis units. Nephron 1981; 29: 105–6.

Popovich R.P. , Moncrief J.W. , Nolph K.D. , Ghods A.J. , Twardowski Z.J. , Pyle W.K. Continuous ambulatory peritoneal dialysis. Ann Intern Med 1978; 88: 449–56.

Fabrizi F. , Martin P. , Lunghi G. , Ponticelli C. Novel evidence on hepatitis B virus infection in dialysis. Int J Artif Organs 2001; 24: 8–16.

Alberù J. , Lisker-Melman M. , Gonzalez M. , Vargas-Vorackova F. , Sixtos S. , Ramirez T. , De Leo C. , Castelan N. , Bordes-Aznar J. , Correa-Rotter R. Prevalence of hepatitis B and C in patients registered on the cadaver kidney transplant waiting list in Mexico. Transplant Proc 1996; 28: 3298–300.

Castelnovo C. , Lunghi G. , De Vecchi A. , Grancini A. , Como G. , Graziani G. , Scalamogna A. , Ponticelli C. Comparison of three different tests for assessment of hepatitis C virus in dialysis patients. Perit Dial Int 1995; 15: 241–5.

Chan T.M. , Lok A.S.F. , Cheng I.K.P. Hepatitis C infection among dialysis patients: A comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991; 6: 944–7.

Dussol B. , Berthezene P. , Brunet P. , Berland Y. , and the Provence-Alpes-Cote d'Azur Nephrologists Group. Hepatitis C virus infection among chronic dialysis patients in the southeast of France. Nephrol Dial Transplant 1995; 10: 477–8.

Dussol B. , Berhezene P. , Brunet P. , Roubicek C. , Berland Y. Hepatitis C virus infection among chronic dialysis patients in the south of France: a collaborative study. Am J Kidney Dis 1995; 25: 399–404.

Golan E. , Korzets Z. , Cristal-Lilov A. , Ben-Tovim T. , Bernheim J. Increased prevalence of HCV antibodies in dialyzed Ashkenazi Jews- a possible ethnic predisposition. Nephrol Dial Transplant 1996; 11: 684–6.

Gladziwa U. , Schlipkoter U. , Lorbeer B. , Cholmakow K. , Roggendorf M. , Sieberth H.G. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis – a multicenter study. Clin Nephrol 1993; 40: 46–52.

Huang C.C. , Wu M.S. , Lin D.Y. , Liaw Y.F. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12: 31–3.

Hung K.Y. , Shyu R.S. , Huang C.H. , Chen W.Y. Viral hepatitis in continuous ambulatory peritoneal dialysis patients in an endemic area for hepatitis B and C infection: The Taiwan experience. Blood Purif 1997; 15: 195–9.

Krautzig S. , Tillmann H. , Wrenger E. , Manns M. , Koch K.M. , Brunkhorst R. Hepatitis C virus (HCV) in peritoneal dialysis (Letter). Clin Nephrol 1994; 41: 120.

Lombardi M. , Cerrai T. , Geatti S. , Negroni S. , Pertusini L. , Pegoraro M. , Di Lullo G. Results of a national epidemiological investigation on HCV infection among dialysis patients (Survey by the Italian Branch of EDTNA-ERCA). J Nephrol 1999; 12: 322–7.

McIntyre P.G. , McCruden E.A.B. , Dow B.C. , Cameron S.O. , McMillan M.A. , Allison M.E.M. , Briggs J.D. Hepatitis C virus infection in renal dialysis patients in Glasgow. Nephrol Dial Transplant 1994; 9: 291–5.

Ng Y.N. , Lee S.D. , Wu S.C. , Yang W.C. , Chiang S.S. , Huang T.P. Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis. J Med Virol 1991; 35: 263–6.

Selgas R. , Martinez-Zapico R. , Auxiliadora Bajo M. , Romero J.R. , Munoz J. , Rinon C. , Miranda B. , Miguel J.L. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center. Perit Dial Int 1992; 12: 28–30.

Schneeberger P.M. , Keur I. , van der Vliet W. , van Hoek K. , Boswijk H. , van Loon A.M. , van Dijk W. , Kauffmann R.H. , Quint W. , van Doorn L.J. Hepatitis C virus infections in dialysis centers in the Netherlands: A national survey by serological and molecular methods. J Clin Microbiol 1998; 36: 1711–5.

Besso L. , Rovere A. , Peano G. , Menardi G. , Fenoglio L.M. , Fenoglio S. , Ghezzi P.M. Prevalence of HCV antibodies in a uraemic population undergoing maintenance dialysis therapy and in the staff members of the dialysis unit. Nephron 1992; 61: 304–6.

Cantù P. , Mangano S. , Masini M. , Limido A. , Crovetti G. , De Filippo C. Prevalence of antibodies against hepatitis C virus in a dialysis unit. Nephron 1992; 61: 337–8.

Brugnano R. , Francisci D. , Quintaliani G. , Gaburri M. , Nori G. , Verdura C. , Giombini L. , Buoncristiani U. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: Evaluation of some risk factors. Nephron 1992; 61: 263–5.

Akpolat T. CAPD: A control strategy to prevent spread of HCV infection in end-stage renal disease. Perit Dial Int 2001; 21: 77–8.

Sayiner A.A. , Zeytinoglu A. , Ozkahya M. HCV infection in haemodialysis and CAPD patients. Nephrol Dial Transplant 1999; 14: 256–7.

Stevens C.E. , Taylor P.E. , Pindyck J. , Choo Q.L. , Bradley D.W. , Kuo G. , Houghton M. Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. JAMA 1990; 263: 49–53.

Sirchia G. , Almini D. , Bellobuono A. , Giovanetti A.M. , Marconi M. , Mercuriali F. , Mozzi F. , Parravicini A. , Pizzi M. , Zanuso F. Prevalence of hepatitis C virus antibodies in Italian blood donors. Vox Sang 1990; 59: 26–9.

Blackmore T.K. , Maddocks P. , Stace N.H. , Hatfield P. Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy, and in the staff caring for them. Aust NZ J Med 1992; 22: 353–7.

Di Bisceglie A.M. Hepatitis C. Lancet 1998; 251: 351–5.

Dawson G.J. , Lesniewski R.R. , Stewart J.L. , Boardway K.M. , Gutierrez R.A. , Pendy L. , Johnson R.G. , Alcalde X. , Rote K.V. , Devare S.G. Detection of antibodies to hepatitis C virus in U.S. blood donors. J Clin Microbiol 1991; 29: 551–6.

Gorriz J.L. , Miguel A. , Garcia-Ramon R. , Gomez-Roldan C. , Olivares J. , Perez-Contreras J. , Lanuza M. , Alvarino J. Absence of seroconversion to hepatitis C virus infection in CAPD patients (Letter). Nephrol Dial Transplant 1997; 12: 373–4.

Medin C. , Allander T. , Roll M. , Jacobson S.H. , Grillner L. Seroconversion to hepatitis C virus in dialysis patients: A retrospective and prospective study. Nephron 1993; 65: 40–5.

Lee G.S.L. , Roy D.K. , Fan F.Y. , Thanaletchumi K. , Woo K.T. Hepatitis C antibodies in patients on peritoneal dialysis. Prevalence and risk factors. Perit Dial Int 1996; 16(suppl 1): S424–8.

Cendoroglo Neto M. , Draibe S.A. , Silva A.E.B. , Ferraz M.L. , Granato C. , Pereira C.A.P. , Sesso R.C. , Gaspar A.M.C. , Ajzen H. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995; 10: 240–6.

Martin P. , Friedman L.S. Chronic viral hepatitis and the management of chronic renal failure. Kidney Int 1995; 47: 1231–41.

Fabrizi F. , Poordad F.F. , Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002; 36: 3–10.

Cendoroglo Neto M. , Rodrigues Manzano S.I. , Canziani M.E. , Silva A.E.B. , Cirenza M.L.F. , de Cintra Sesso R. , Ajzen H. , Draibe S.A. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Int J Artif Organs 1995; 19: 251–5.

Gorriz J.L. , Miguel A. , Garcia-Ramon R. , Gomez-Roldan C. , Olivares J. , Perez-Contreras J. , Lanuza M. , Alvarino J. Prevalence and risk factors for hepatitis C virus infection in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant 1996; 11: 1109–12.

Perez-Fontan M. , Moncalian J. , Rodriguez-Carmona A. , Arrojo F. Prevalence of antihepatitis C antibodies in patients treated with continuous ambulatory peritoneal dialysis and hemodialysis (Letter). Nephron 1991; 58: 381–2.

Durand P.Y. , Chanliau J. , Gamberoni J. , Hestin D. , Kessler M. , and all the French PD Centers. Prevalence and epidemiology of hepatitis C infection in patients on peritoneal dialysis in France. Adv Perit Dial 1996; 12: 167–70.

Koziol D.E. , Holland P.V. , Alling D.W. , Melpolder J.C. , Solomon R.E. , Purcell R.H. , Hudson L.M. , Shoup F.J. , Krakaner H. , Alter M.J. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986; 104: 448–95.

Serfaty L. , Giral P. , Elghouzzi M.H. , Jullien A.M. , Poupon R. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case control study. Hepatology 1993; 17: 183–7.

Salo R.J. , Salo A. , Fahlberg W.J. , Ellzey J.T. Hepatitis B surface antigen (HBsAg) in peritoneal fluid of HBsAg carriers undergoing peritoneal dialysis. J Med Virol 1980; 6: 29–35.

Caramelo C. , Navas S. , Alberola M.L. , Bermejillo T. , Reyero A. , Carreno V. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994; 66: 470–3.

Castelnovo C. , Sampietro M. , De Vecchi A. , Corbetta N. , Cantù M. , Orlandi A. , Lunghi G. , Ponticelli C. Diffusion of HCV through peritoneal membrane in HCV positive patients treated with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1997; 12: 978–80.

Nakayama E. , Akiba T. , Marumo F. , Sato C. Prognosis of antihepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000; 11: 1896–902.

Espinosa M. , Martin-Malo A. , Alvarez de Lara M.A. , Alijama P. Risk of death and liver cirrhosis in anti-HCV positive long-term haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1669–74.

Stehman-Breen C.O. , Emerson S. , Gretch D. , Johnson R.J. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998; 32: 629–34.

Wolf P.L. , Williams D. , Coplon N. , Coulson A.S. Low aspartate transaminase activity in serum of patients undergoing chronic hemodialysis. Clin Chem 1972; 18: 567–8.

Cohen G.A. , Goffinet J.A. , Donabedian R.K. , Conn H.O. Observations on decreased serum glutamic oxalacetic transaminase (SGOT) activity in azotemic patients. Ann Intern Med 1976; 84: 275–80.

Warnock L.G. , Stone W.J. , Wagner C. Decreased aspartate aminotrasferase “SGOT” activity in serum of uremic patients. Clin Chem 1974; 20: 1213–6.

Crawford D.R. , Reyna R.S. , Weiner M.W. Effects of in vivo and in vitro dialysis on plasma transaminase activity. Nephron 1978; 22: 418–22.

Bailey G.L. , Katz A.I. , Hampers C.L. , Merrill J.P. Alterations in serum enzymes in chronic renal failure. JAMA 1970; 213: 2263–5.

Yasuda K. , Okuda K. , Endo N. , Ishiwatari Y. , Ikeda R. , Hayashi H. , Yokozeki S. , Kobayashi S. , Irie Y. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 1995; 109: 1295–300.

Hung K.Y. , Lee K.C. , Yen C.J. , Wu K.D. , Tsai T.J. , Chen W.Y. Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: Experience from Taiwan, an endemic area for hepatitis B. Nephrol Dial Transplant 1997; 12: 180–3.

Fabrizi F. , Lunghi G. , Andrulli S. , Pagliari B. , Mangano S. , Faranna P. , Pagano A. , Locatelli F. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant 1997; 12: 1394–8.

Fabrizi F. , Lunghi G. , Finazzi S. , Colucci P. , Pagano A. , Ponticelli C. , Locatelli F. Decreased serum aminotransferase activity in patients with chronic renal failure: Impact on the detection of viral hepatitis. Am J Kidney Dis 2001; 38: 1009–15.

Guh J.Y. , Lai Y.H. , Yang C.Y. , Chen S.C. , Chuang W.L. , Hsu T.C. , Chen H.C. , Chang W.Y. , Tsai J.H. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 1995; 69: 459–65.

Centers for Disease Control and Prevention (CDC). Recommendations for preventing transmission of infections among chronic hemodialysis patients. Morb Mortal Wkly Rep 2001; 50: 1–43.

Kellerman S. , Alter M.J. Preventing hepatitis B and C virus in end-stage renal disease patients: Back to basics. Hepatology 1999; 29: 291–3.

The EBPG Expert Group on Haemodialysis. European best practice guidelines for haemodialysis (Part 1). Section VI. Haemodialysis-associated infection. Nephrol Dial Transplant 2002; 17(suppl 7): S72–87.

Schmid E. , Augustin R. , Machleidt C. , Wisser H. , Kuhlmann U. Efficacy of hepatitis B vaccination in patients on CAPD compared to patients on hemodialysis. Adv Perit Dial 1987; 3: 61–5.

Dacko C. , Holley I.L. The influence of nutritional status, dialysis adequacy, and residual renal function on the response to hepatitis B vaccination in peritoneal dialysis patients. Adv Perit Dial 1996; 12: 315–7.

Khan A.N. , Bernardini J. , Rault R.M. , Piraino B. Low seroconversion with hepatitis B vaccination in peritoneal dialysis patients. Perit Dial Int 1996; 16: 370–3.

Holley J.L. Does the response to hepatitis B vaccination predict CAPD associated infections? Adv Perit Dial 1996; 12: 218–20.